INFLUENCE SEX STEROID HORMONES ON THE CARDIOVASCULAR SYSTEM OF WOMEN

INFLUENCE SEX STEROID HORMONES ON THE CARDIOVASCULAR SYSTEM OF WOMEN

Narzullaeva A.R., Rakhimov Z.Y., Muradov A.M., Rofieva H.Sh.

Department of Cardiology with the course of clinical pharmacology of Tajik Institute of Post-Graduate Education of Medical Staff

The review describes the questions of influence of sex hormones on the cardiovascular system. Data provided nu­merous studies show a veracious cardioprotective effect of female sex hormones, which manifests itself in pronounced vasodilatory, anti-atherogenic, and antiagregatine anticoagulant action aimed at preventing the pathological changes in the cardiovascular system.

REFERENCES

1. Baranova E. I., Bolshakova O. O., Bagrov A. Ya., Nutfullina G. M., Kuznetsova I. A., Minasyan S. M., Yusi-pova T. Kh. Effect of drospirenone on the remodeling of the cardiovascular system in conditions of artificial menopause in experiment.

Regional circulation and microcirculation, 2012, no. 2, pp. 47-51.

2. Velizhanina E. S., Gapon L. I., Velizhanina I. A. Features of the course of arterial hypertension in period of menopause.

Cardiovascular Therapy and Prevention, 2009, no. 6, pp. 57-58.

3. Golikov A. P., Ryabinin V. A. Way of correction arterial hypertension in metabolic syndrome.

Russian Medical Journal, 2008, no. 6, pp. 51-53.

4. Grigoryan O. R., Andreeva R. Kh. Menopauzalnyy metabolicheskiy sindrom (klinika, diagnostika, lechenie). Nauchno-prakticheskoe rukovodstvo [Menopausal metabolic syndrome (clinic, diagnosis, treatment). Scientific and prac­tical guide]. Moscow, Intel Tek Publ., 2007. 5-22 p.

5. Gurevich M. A., Arkhipova L. V. Peculiarities of clin­ical course and treatment of ischemic heart disease in women.

Diseases of the heart and blood vessels, 2009, no.1, pp. 32-35.

6. Dotsenko Yu. V., Lupanov V. P., Lipman A. D. An­giotensin receptor blockers II (ATI subtype) in the treatment of arterial hypertension in menopausal of women.

Obstetrics and Gynecology, 2009, no. 2, pp. 8-11

7. Doskina E. V. Pathophysiological therapy menopaus-al age women with metabolic syndrome.

Attending doctor, 2013, no. 3, pp. 87-90.

8. Pines A., Sturdee D. W., Birkhauser M. H., de Villiers T., Naftolin F., Gompel A., Farmer R., Barlow D. , Tan D., Maki P., Lobo R., Hodis H., Zamestitelnaya gormonalnaya terapiya v ranney postmenopauze. Nauchnye dannye i predubezhdeniya [Hormone replacement therapy in menopause. Scientific evidence and prejudice]. Avaible at: http://www.climax.ru/patients/articles/article. aspx-?id=5800&rid=40. 2008.

9. Kovalenko L. V., Belotserkovtseva L. D., Korneeva E. V. Pathogenetic substantiation of therapy for metabolic disorders in women on estrogen deficiency.

Attending doctor, 2011, no. 7, pp. 56-60.

10. Manukhin I. B., Taktarov V. G., Shmeleva S. V. Zdorove zhenshchiny vklimakterii. Rukovodstvo dlya vrachey [Health of the woman in climacteric. Manual for Physicians]. Moscow, Litterra Publ., 2010. 21-44 p.

11. Podzolkov V. I. Osadchiy K. K. Treatment of hyper­tension in menopausal metabolic syndrome: whether there was a place for P-adrenergic blockers?

Consilium medicum, 2008, no. 11, pp. 5-11.

12. Ratsionalnaya farmakoterapiya v akusherstve, gine-kologii i neonatologii. pod red. G.T. Sukhikh, V. N. Serova [Rational pharmacotherapy in obstetrics, gynecology and neonatology. Under the editorship G.T. Sukhikh, V. N. Serov]. Moscow, Litterra Publ., 2010. Vol. 2, 736 p.

13. Smetnik, V. P., Kulakova, V. I. Rukovodstvo po kli-makteriyu [Manual for Menopause]. 2007. 14-15 p.

14. Smetnik V. P., Kasyan V. N., Smetnik A. A., Estrog-eny: ot sinteza do klinicheskogo primeneniya. Pod red. V. P. Smetnika [Estrogens: from synthesis to clinical application. Under the editorship V. P. Smetnik]. Moscow, Prakticheska-ya meditsina Publ., 2012. 174 p.

15. Tarasova M.A., Effect of substitution therapy 17 P-estradiol combined with drospirenone on the dynamics of blood pressure, endothelium-dependent vasodilation and endothelium in postmenopausal women.

Journal of Obstetrics and women's diseases, 2007, Vol. 56, ussue 2, pp. 3-8.

16. Ustinova S. E., Yarnykh E. V., Masenko V. P., Arabidze G. G. Features of the functional state of the dopa-minergic system among women with arterial hypertension menopause.

Therapeutic Archives, 2000, no. 1, pp. 35-40.

17. Chazova I. E. Conduction women with cardiovascular risk in the perimenopausal and postmenopausal: consensus of Russian cardiologists and gynecologists.

Consilium medicum, 2008, Vol. 10, no. 6, pp. 5-18.

18. Chazova I. E., Mychka V. B. Metabolicheskiy sindrom [Metabolic syndrome]. Moscow, Media Medika Publ., 2008.

19. Collins R Rosano G, Casey C., Conduction women with cardiovascular risk in perimenopause: consensus of European cardiologists and gynecologists.

Climacteric, 2007, Vol. 10, pp. 508-526.

20. Grodstein F., Manson J.E., Stampfer J., Rexrode K. Postmenopausal hormone therapy and stroke. The role of time since menopause and age of initiation of hormone therapy.

Archives of Internal Medicine, 2008, Vol. 168, pp. 861-866.

21. Master F.L., Dea K., Duh M.S., Does route of ad­ministration for estrogen hormone therapy impact risk of venous thromboembolism?: estradiol transdermal system vs. oral estrogen only hormone therapy. NAMS 21-st Annual Meeting (Abstract book). Chicago, 2010.

 

Комментарии

Back to Top